01 4Zepzelca
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 90
2019 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 247
2020 Revenue in Millions : 90
Growth (%) : 173
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 270
2021 Revenue in Millions : 247
Growth (%) : 9
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 290
2022 Revenue in Millions : 270
Growth (%) : 7
LOOKING FOR A SUPPLIER?